Haleon Appoints Richard Manson as Chief Marketing Officer

Haleon – the company behind healthcare brands such as Panadol and Sensodyne – has appointed a new Chief Marketing Officer. 

Richard Manso will lead the company’s integrated US marketing organisation to combine data, technology and human insight as part of Haleon’s plan to deliver more personalised, transparent and relevant healthcare. 

He replaces former CMO Tamara Rogers, who announced that she was leaving the company in February.

Digital marketing leadership

Richard joins Haleon from a range of leadership roles across marketing, technology and digital transformation – most recently serving as Senior Director of Global Ads Marketing at Google. In this role, he led large-scale B2B marketing programmes, and helped drive the adoption of data and AI-enabled marketing solutions. 

Prior to that, he spent more than 12 years at L'Oréal, joining as a Senior Ecommerce Manager for the company’s Luxe division, before progressing to the Chief Digital and Marketing Officer of L'Oréal Dermatological Beauty. 

“I’m excited to join Haleon at such a pivotal moment for both the company and the consumer health category,” he says. “As people take greater ownership of their health, there’s a real opportunity to rethink how brands show up, not just as products, but as trusted partners in everyday life. 

“I’m looking forward to working with Nathalie and the team to bring together data, technology, and creativity to build more meaningful connections with consumers and drive the next phase of growth.”

Alongside the Chief Marketing Officer role, Haleon has also introduced a new Chief Growth Officer position, which Filippo Lanzi took on after Tamara’s departure, in which he has been overseeing marketing alongside other commercial functions – which Tamara said in an interview with Marketing Week would ensure “integrated thinking from the get-go.”

“We’ve got this opportunity, which I think is incredibly exciting, for marketing actually to shape an even broader agenda,” she continued. 

Shifts in consumer healthcare marketing

Richard’s appointment comes at a time of significant transformation in consumer health, with customers taking a more active and self-directed role in managing their wellbeing. According to Haleon, as customers begin to expect more personalised and on-demand experiences, marketing is emerging as a critical driver of trust, shaping how healthcare companies are showing up across touchpoints in everyday life.

To lead this transformation at Haleon, Richard’s role will involve strengthening the company’s marketing capabilities across the US business, driving growth across categories and advancing priority areas – such as Medicare Advantage OTC, GLP-1 and emerging platforms such as Women’s and Pediatric Health. 

He will also support the company’s wider ambition to build a more connected and insight-led marketing ecosystem to better reflect how consumers are engaging with their health 

“Consumers are taking a more active role in managing their health – and that’s raising expectations for the brands they trust,” says Nathalie Gerschtein, US CEO and President, North America of Haleon. “At Haleon, we see an opportunity to rethink how we engage – making it more personal, transparent and connected to the moments where health decisions happen. 

“Richard brings a forward-looking perspective at the intersection of marketing, data and technology that will help us continue to evolve and deliver better everyday health with humanity.”